VIRIDIEN 114.200 € (-4,36 %)
AYVENS 11.300 € (-0,88 %)
KLEA HOLDING 0.182 € (-3,19 %)
CVC CAPITAL 13.480 € (-0,44 %)
LOUIS HACHETTE 1.577 € (-4,42 %)
STIF 50.650 € (-1,65 %)
SCHNEIDER ELECTRIC 278.800 € (-1,38 %)
NOVACYT 0.480 € (+39,74 %)
CARMILA 17.040 € (-0,58 %)
FUGRO 11.650 € (-2,92 %)
MAGNUM 12.426 € (-3,79 %)
AIRBUS 184.220 € (-2,27 %)
STELLANTIS NV 6.390 € (-1,33 %)
SANOFI 74.140 € (-0,67 %)
SOITEC 154.000 € (+4,87 %)
SHELL PLC 35.955 € (-3,22 %)
RENAULT 31.120 € (+1,37 %)
SOPRA STERIA GROUP 141.200 € (-0,42 %)
THALES 235.800 € (-2,16 %)
TOTALENERGIES 74.820 € (-2,51 %)
SAFRAN 298.400 € (+0,57 %)
GALAPAGOS 23.540 € (-4,39 %)
HEIJMANS KON 91.800 € (+1,60 %)
MICHELIN 32.210 € (+0,25 %)
DASSAULT AVIATION 302.800 € (-1,62 %)
DSM FIRMENICH AG 66.540 € (-2,72 %)
ADYEN 957.400 € (-0,02 %)
ASR NEDERLAND 65.640 € (-0,15 %)
DBV TECHNOLOGIES 3.400 € (-1,45 %)
WOLTERS KLUWER 61.420 € (-3,15 %)
LVMH 480.000 € (+1,27 %)
STMICROELECTRONICS 48.510 € (+0,02 %)
EXAIL TECHNOLOGIES 113.700 € (-6,34 %)
X-FAB 6.710 € (-0,15 %)
ASML HOLDING 1 305.000 € (0,00 %)
VALLOUREC 23.560 € (-5,23 %)
EDENRED 21.230 € (-0,84 %)
ALSTOM 17.770 € (+1,08 %)
ING GROEP N.V. 25.850 € (+1,25 %)
BE SEMICONDUCTOR 258.100 € (+1,22 %)
TECHNIP ENERGIES 38.180 € (-4,98 %)
DASSAULT SYSTEMES 19.775 € (+0,03 %)
PHARMING GROUP 1.047 € (-24,98 %)
ARKEMA 62.950 € (-1,95 %)
AKZO NOBEL 51.440 € (+0,19 %)
RANDSTAD NV 25.520 € (-0,08 %)
AIR FRANCE -KLM 10.675 € (+3,59 %)
EXOSENS 61.900 € (-3,81 %)
CROSSJECT 2.060 € (+4,99 %)
SOCIETE GENERALE 70.290 € (+0,41 %)
ENGIE 27.010 € (-2,03 %)
AIR LIQUIDE 176.000 € (-2,37 %)
LDC 114.400 € (+0,53 %)
PROSUS 42.140 € (+0,62 %)
L'OREAL 367.850 € (-1,49 %)
PHILIPS KON 23.580 € (+1,86 %)
BNP PARIBAS ACT.A 93.380 € (-0,03 %)
VEOLIA ENVIRON. 36.160 € (-0,11 %)
VALNEVA 2.453 € (+5,82 %)
IPSOS 37.280 € (-0,80 %) |
16/04/2026 18:02
Covivio - Description of the share buy-back program authorized by the Combined Ordinary and Extraordinary Shareholders’ Meeting held on 16 April 2026Paris, 16th April 2026 Description of the share buy-back program authorized by the Combined Ordinary and Extraordinary Shareholders’ Meeting held on 16 April 2026OVERVIEW OF THE MAIN FEATURES OF THE SHARE BUY-BACK PROGRAM
Pursuant to Article 241-2 of the Règlement général de l’Autorité des marchés financiers (AMF), the purpose of this document is to describe the aims and terms of the share buy-back program authorized by the Combined Ordinary and Extraordinary Shareholders’ Meeting of Covivio held on 16 April 2026. INFORMATION ON THE SHARE BUY-BACK PROGRAM1. AIMS OF THE SHARE BUY-BACK PROGRAM AND USE OF THE SHARES REPURCHASEDThe aims of the share buy-back program authorized by the seventeenth resolution approved by the Combined Ordinary and Extraordinary Shareholders’ Meeting of 16 April 2026 are the following:
In the context of the achievement of the fifth aim referred to above, in order to avoid excessive volatility of the share price, Covivio entrusted Exane (investment services provider), as of 11 July 2005, with the implementation of a liquidity contract. A new liquidity contract was entered into with Exane on 10 January 2019, with effect on 1st January 2019, in accordance with Regulation (EU) No 596/2014 of the European Parliament and of the Council of 16 April 2014 on market abuse, Commission Delegated Regulation (EU) 2016/908 of 26 February 2016, which was updated with effect on 1st July 2021 following AMF Decision No 2021-01 of 22 June 2021 on renewal of establishment of liquidity contracts on capital securities as an accepted market practice. Under the terms of the agreement to transfer the liquidity contract signed on 5 September 2023 between Exane, BNP Paribas Financial Markets (formerly BNP Paribas Arbitrage) and Covivio, the liquidity contract was transferred from 23 October 2023 to BNP Paribas Financial Markets. It is recalled that pursuant to the provisions of the liquidity contract transferred to BNP Paribas Financial Markets:
Subject to the approval of the seventeenth resolution by the General Meeting of 16 April 2026 (the “Condition Precedent”), the Board of Directors decided on 15 April 2026 to implement a new share buy-back program, notably through the extension of the existing liquidity contract with BNP Paribas Financial Markets, under the same conditions and on the basis of a maximum purchase price of €85 per share (excluding acquisitions costs). Pursuant to decision dated 16 April 2026, the Chief Executive Officer acknowledged that the Condition Precedent is completed and confirmed, if required, the implementation of the share buy-back program, under the terms and condition determined by the Board of Directors. For the continuation of this contract, scheduled from the implementation of this program, Covivio kept the resources allocated to the liquidity account, being specified that on the date of 16 April 2026, the following resources were allocated to the liquidity account:
In with the context of the implementation of this program, the maximum amount of funds allocated to the share buy-back program amounts to €500,000,000. 2. NUMBER OF SHARES HELD BY COVIVIO – BREAKDOWN OF THE SHARES HELD PER AIMBefore 16 April 2026, a share buy-back program was authorized by the Combined Ordinary and Extraordinary Shareholders’ Meeting of Covivio held on 17 April 2025, and which terms and conditions were described in the overview of the said program made public on 17 April 2025. As of 16 April 2026, Covivio holds as of the date of this overview:
The Company did not use any derivatives under this previous share buy-back program. 3. LEGAL FRAMEWORKThis program is made in accordance with the provisions of:
This buy-back program was authorized by the seventeenth resolution approved by the Combined Ordinary and Extraordinary Shareholders’ Meeting of 16 April 2026. 4. TERMS4.1. Characteristics of the shares concerned by the share buy-back programCovivio ordinary shares (ISIN Code: FR0000064578), all of the same category, bearer or registered, listed on Euronext Paris – Compartment A. 4.2. Maximum portion of the share capital that may be acquired and maximum amount payable by CovivioPursuant to the resolution approved by the Combined Ordinary and Extraordinary Shareholders’ Meeting of Covivio held on 16 April 2026, the number of shares that the Company is authorized to purchase shall not exceed 10% of the shares composing the Company’s share capital (at any given time, this percentage shall apply to the share capital taking into account transactions affecting it after the Shareholders’ General Meeting), i.e. for information purposes 11,162,346 shares on the date of this overview. It is specified that in the event of a purchase under the liquidity contract, the number of shares considered for the calculation of the limit of 10% of the above-mentioned amount of share capital shall correspond to the number of shares purchased, less the number of shares resold during the term of this authorization. However, the number of shares purchased in view of conserving them and handing them over subsequently for payment or exchange within the context of a merger, demerger or contribution, shall not exceed 5% of the Company’s share capital. The maximum purchase price per share is set at €85 (excluding purchase costs). On the basis of the number of shares composing the share capital on the date of this overview (111,623,468 shares) and taking into account 844,486 treasury shares, the maximum number of shares that is likely to be purchased would amount to 10,317,860 shares. However, it is recalled that pursuant to the seventeenth resolution approved by the Combined Ordinary and Extraordinary Shareholders’ Meeting of Covivio held on 16 April 2026, the maximum amount of funds allocated to the share buy-back program is one hundred and five hundred million euros (€500,000,000). 4.3. Terms and conditions of the repurchaseThe acquisition, sale, exchange or transfer of shares may be carried out at any time, except as from the filing by a third party of a tender offer on the Company's shares, until the end of the offer period, and by any means, including by trading on a regulated market or a multilateral trading facility, with systematic internalisers or over the counter particularly including through the acquisition or sale of blocks of shares (on or off the market), takeover or public exchange offering, as well as through the use of financial instruments, specifically derivative financial instruments traded on a regulated or over-the-counter market, such as calls or puts options or any combinations thereof, or by recourse to warrants, either directly or indirectly through an investment service provider, under the conditions authorised by the competent market authorities and at such times as the Company’s Board of Directors deems fit. The maximum portion of the share capital acquired or transferred in the form of blocks of shares may comprise up to the entire program. In the event of a change in the par value of the share, a capital increase by incorporation of reserves, a free allocation of shares, a split or regrouping of shares, a distribution of reserves or of any other assets, a capital depreciation or any other transaction relating to the shareholders' equity, the maximum purchase price will be adjusted by decision of the Board of Directors to take into account the impact of these transactions on the value of the share. 4.4. Duration of the share buy-back program and calendarThis share buy-back program shall be implemented within a limited period of eighteen (18) months starting from the date of the Combined Ordinary and Extraordinary Shareholders’ Meeting, i.e. until 15 October 2027 at the latest. 4.5. Financing of the share buy-back programThe purchases will be financed in part by Covivio’s own resources or, where applicable, by means of debts for additional needs that exceed its self-financing. 5. UNIVERSAL REGISTRATION DOCUMENTThe universal registration document of Covivio for the year ended 31 December 2025 was filed within the Autorité des marchés financiers on 18 March 2026 under number D.26-0107. CONTACTSPress Relations Louise-Marie Guinet Investor Relations ABOUT COVIVIOThanks to its partnering history, its real estate expertise and its European culture, Covivio is inventing today’s user experience and designing tomorrow’s city. A preferred real estate player at the European level, Covivio is close to its end users, capturing their aspirations, combining work, travel, living, and co-inventing vibrant spaces. A benchmark in the European real estate market with €23.7 bn in assets, Covivio offers support to companies, hotel brands and territories in their pursuit for attractiveness, transformation and responsible performance. Build sustainable relationships and well-being, is the Covivio’s Purpose who expresses its role as a responsible real estate operator to all its stakeholders: customers, shareholders and financial partners, internal teams, local authorities but also to future generations and the planet. Furthermore, its living, dynamic approach opens up exciting project and career prospects for its teams. Covivio’s shares are listed in the Euronext Paris A compartment (FR0000064578 - COV), are admitted to trading on the SRD, and are included in the composition of the MSCI, SBF 120, Euronext IEIF “SIIC France” and CAC Mid100 indices, in the “EPRA” and “GPR 250” benchmark European real estate indices, and in the ESG FTSE4 Good, DJSI World & Europe, Euronext (Sustainable World 120, Sustainable Euro 120, CDP Environment ESG France EW, SBF Top 50 ESG, SBT 1.5°), Stoxx ESG, Ethibel and Gaïa, and has received recognition and ratings from EPRA BPRs Gold Awards (financial reporting and sustainable development), CDP (A-), GRESB (91/100, 5-Star, 100% public disclosure), ISS-ESG (B-) and MSCI (AAA). Notations solicited: Source : Webdisclosure.com |
Cotations différées d'au moins 15 minutes (Paris, Amsterdam, Bruxelles, Lisbonne).
Cotations à la clôture (Francfort, New-York, Londres, Zurich).
Flux de cotations : Euronext (Places Euronext et Cours des Devises).
Bourse : technologie Cote Boursière